Clinical Trial Update: Pilot Study of Reduced Venetoclax Exposure [Phase 2]

View source ↗

Summary

Phase 2 pilot study updating on reduced venetoclax exposure in patients with acute myeloid leukemia in remission; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Venetoclax (Venclexta) (venetoclax)

Snippet

Sponsor: Northwell Health | Conditions: Acute Myeloid Leukemia in Remission | Phase 2 | Status: RECRUITING